The present disclosure is generally related to providing cannabis recommendations to users based on physiological values in real time.
Cannabis contains a unique class of terpeno-phenolic compounds known as cannabinoids or phytocannabinoids. The principle cannabinoids present in cannabis are tetrahydrocannabinol (THC), which is a potent psychoactive cannabinoid and cannabidiol (CBD), which is non-psychoactive but is widely known to have therapeutic potential for a variety of medical conditions. The proportion of cannabinoids in the plant may vary from strain to strain. Based on the proportion of the cannabinoids present in a plant variety, the psychoactive and medicinal effects obtained from different plant varieties may vary. Such variance is further exacerbated by the presence of certain terpenoid or phenolic compounds which may be present in the plant, which may also have pharmacological activity.
Cannabis can reduce stress and anxiety in users. However, the variety of cannabis strains is as wide as the variety of stressors in the world. Given how effects of cannabis can vary greatly from strain to strain, it is important for users to identify the best strain for a given situation.
The present disclosure is a wearable sensor technology that quantifies and categorizes stress to recommend the correct strain of cannabis to a user in a given situation. The present disclosure is a method of providing cannabis users with more effective stress relief by using a recommendation network to collect cannabis usage and stress sensor data and correlate stress reduction to specific cannabis products.
A cloud or communication network 116 may be a wired and/or a wireless network. The network 116, if wireless, may be implemented using communication techniques such as visible light communication (VLC), worldwide interoperability for microwave access (WiMAX), long term evolution (LTE), wireless local area network (WLAN), infrared (IR) communication, public switched telephone network (PSTN), radio waves, and other communication techniques known in the art. The network 116 may allow ubiquitous access to shared pools of configurable system resources and higher-level services that can be rapidly provisioned with minimal management effort, often over Internet and relies on sharing of resources to achieve coherence and economies of scale, like a public utility, while third-party clouds enable organizations to focus on their core businesses instead of expending resources on computer infrastructure and maintenance.
A user device 118 (e.g., laptop, smartphone, tablet, smart watch, etc.) facilitates the collection of data from the intake device 124 and the wearable stress sensor(s) 126 and transmits that data via its communication hardware to the recommendation network 102. An inventory database 120 is populated by the user, cataloging the amount of and type of cannabis products they currently have. In other embodiments, this would be populated by point of sale systems at cannabis stores or dispensaries. A usage app 122, such as Releaf, allows the user to track their cannabis usage and populate the inventory database 120. Other usage applications may also be used to receive data from the user, as well as to communicate data (e.g., a recommendation) to the user by way of a displayed message or notification.
In one example, the intake device 124 is a vaporizing device for delivering cannabis products to the user, while monitoring use levels and communicating that information wirelessly to another device. One or more wearable stress sensor(s) 126 can quantify the level of stress a wearer is experiencing (e.g., on a scale of 1-10) and categorize the stress into at least two different types (e.g., chronic or acute).
The process begins at 200 with a new data event detected in the stress sensor database 114. At step 202, the monitoring module 104 calls the correlation module 106 to update the correlation coefficients between consumption of a specific cannabis strain (e.g., strain A, B or C) and a reduction in a specific type of stress (e.g., 6 out of 10 and acute). At 204, the monitoring module 104 determines if the user is stressed from the current wearable stress sensor data in the stress sensor database 114. If the user is determined to be stressed, the recommendation module 108 is called at 206. At 208, the monitoring module 104 then polls for the next new data event in the stress sensor database 114 to begin the process again.
The process begins at 300 when usage data is received from the monitoring module 104. At 302, the usage database 112 is queried for the cannabis strain the user is currently using. At 304, the correlation database 110 is filtered for correlations related to the current strain. At 306, the first data (e.g., level 6 out of 10 acute stress) is selected. At 308, the correlation calculations are run for all the data that has the same level and type of stress. At 310, it is determined if there is a correlation coefficient greater than 0.95 (an arbitrarily chosen threshold for the purposes of this example). If the correlation coefficient is above the predetermined threshold, the steepest downward sloping stress curve is selected and extracted (e.g., strain A 50 mg) at 312. At 314, the identified data point is written to correlation database 110. At 316, it is determined if there are any parameters left. If yes, the next parameter is examined at 318. If no, the process returns to the monitoring module 104 at 320.
The process begins at 400 when stress data is received from the monitoring module 104. At 402, the correlation database 110 is queried for the cannabis strain(s) correlated to a downward sloping curve of stress data produced by the user's wearable stress sensor(s) 126. At 404, the inventory database 120 is queried for any of the cannabis strains identified as correlated to downward sloping stress curves. At 406, it is determined if any correlated strains are present in the inventory database 120. At 408, the cannabis strain in the inventory database 120 that is most similar in attributes (e.g., indica vs. sativa, THC percentage, THC/CBD ratio, etc.) to correlated strains is identified. At 410, the cannabis strains in the inventory database 120 are ranked by the downward slope of the stress curve in the correlation database 110. At 412, the strain recommendations are presented to the user on the usage app 122. At 414, the process returns to the monitoring module 104.
Although the present disclosure and its advantages have been described in detail, it should be understood that various changes, substitutions and alterations can be made herein without departing from the disclosure as defined by the appended claims. Moreover, the scope of the present application is not intended to be limited to the particular embodiments of the process, machine, manufacture, composition of matter, means, methods and steps described in the specification. As one will readily appreciate from the disclosure, processes, machines, manufacture, compositions of matter, means, methods, or steps, presently existing or later to be developed that perform substantially the same function or achieve substantially the same result as the corresponding embodiments described herein may be utilized. Accordingly, the appended claims are intended to include within their scope such processes, machines, manufacture, compositions of matter, means, methods, or steps.
The present patent application is a continuation of International Application No. PCT/IB2019/058792 filed Oct. 15, 2019, which claims the priority benefit of U.S. provisional patent No. 62/750,210 filed Oct. 24, 2018, the disclosures of which are incorporated by reference herein.
| Number | Date | Country | |
|---|---|---|---|
| Parent | PCT/IB2019/058792 | Oct 2019 | US |
| Child | 17240557 | US | |
| Parent | 62750210 | Oct 2018 | US |
| Child | PCT/IB2019/058792 | US |